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Abstract. Mitosis count is an important biomarker for prognosis of var-
ious cancers. At present, pathologists typically perform manual counting
on a few selected regions of interest in breast whole-slide-images (WSIs)
of patient biopsies. This task is very time-consuming, tedious and sub-
jective. Automated mitosis detection methods have made great advances
in recent years. However, these methods require exhaustive labeling of a
large number of selected regions of interest. This task is very expensive
because expert pathologists are needed for reliable and accurate anno-
tations. In this paper, we present a semi-supervised mitosis detection
method which is designed to leverage a large number of unlabeled breast
cancer WSIs. As a result, our method capitalizes on the growing number
of digitized histology images, without relying on exhaustive annotations,
subsequently improving mitosis detection. Our method first learns a mi-
tosis detector from labeled data, uses this detector to mine additional
mitosis samples from unlabeled WSIs, and then trains the final model
using this larger and diverse set of mitosis samples. The use of unlabeled
data improves F1-score by ∼5% compared to our best performing fully-
supervised model on the TUPAC validation set. Our submission (single
model) to TUPAC challenge ranks highly on the leaderboard with an
F1-score of 0.64.
Keywords: Mitosis detection, computational pathology, breast cancer,
self-supervised learning, semi-supervised learning
1 Introduction
Precise quantification of mitotic figures in hematoxylin and eosin (H&E) stained
slides is of high clinical significance in understanding the proliferation activity
of cells within tumor regions. In breast cancer, mitosis count is a significant
prognostic biomarker and one of the most important criteria for cancer grad-
ing. In routine clinical practice, a pathologist visually examines H&E stained
slides under the microscope. This conventional way of mitosis counting is ex-
tremely time-consuming and tedious, as a pathologist has to perform this task
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for several high-power-fields (HPF) in multiple whole-slide-images (WSI) for a
single patient. In addition, this process is extremely subjective with noticeable
disagreement between different pathologists [17], mainly due to the inherent
ambiguity and difficulty of the task. Automated methods have the potential to
overcome the inter- and intra-observer variability by producing more consistent
results and freeing up valuable pathologist’s time which can be better spent on
understanding the aggressiveness of disease and stratified medicine.
Mitosis detection is considered a challenging task even for experienced pathol-
ogists due to the variations in morphological appearance of mitotic cells (see
Fig. 2). These variations are caused by various factors including the mitotic
phase, staining variability and tissue damage during the slide preparation. Mi-
totic cells typically look like hyper-chromatic objects without nuclear membrane,
which have hairy extensions of nuclear material [17]. However, there are many
instances in which these characteristic features are difficult to spot and subjec-
tive decisions have to be made. These subjective decisions can be challenging due
to the presence of other cells, such as apoptotic (programmed cell death) cells,
which have very similar appearances. In addition, mitotic cells are significantly
less in number as compared to other malignant and healthy cells. Hence, the
detection of mitotic cells naturally suffers from a huge class imbalance.
In recent years, several mitosis detection challenges have been organized: MI-
TOS12 [14]; AMIDA13 [18]; MITOS14 [1]; and TUPAC [2]. These challenges have
tackled increasingly more difficult scenarios and have greatly helped to advance
mitosis detection research. Regardless, one of the shortcomings of these contest
datasets is the limited number of mitosis samples and pathology centers from
which the data is acquired, limiting the generalization ability of trained mitosis
detectors. State-of-the-art deep learning based methods require a large number
of annotated samples for training. One approach for increasing the number of
annotations is semi-supervised learning, which can make good use of readily
available unlabeled data in histopathology.
With regards to the previously mentioned challenges, we propose a deep
learning based self-supervised algorithm that makes use of both labeled HPFs
and unlabeled WSIs to train the mitosis detector. We show that mitosis detection
can benefit from larger datasets and in the absence of a large amount of labeled
data, leveraging an unlabeled dataset can lead to a significant improvement in
the performance of current mitosis detection methods.
2 Related research
Automated methods have shown great promise in detecting mitotic cells [5,7,11]
within histological images in recent years. Mitosis detection was among the first
few problems where deep learning showed its potential, when a convolutional
neural network (CNN) [5] out-performed competing methods by a large margin
in MITOS12 challenge [14]. This method detected mitosis by scanning an image
in a sliding window manner. This was followed by a fully convolutional ver-
sion, which significantly reduced the test inference time and won the AMIDA13
challenge by a convincing margin [18].
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Since then, there have been many advances to improve the performance of
these methods. Some of the most recent methods have made use of deeper [11],
wider [19] and cascades of networks [4]. Recently, the use of crowd-sourced an-
notations [3] has been explored for this task and despite these annotations being
noisy, the proposed aggregation layer can lead to good performance. PHH3 la-
beling has also been used to create larger mitosis detection datasets [16].
In the last couple of years, semi- and weakly-supervised methods have shown
their potential in improving performance beyond the limits of state-of-the-art
fully-supervised methods. Sun et al. [15] showed the importance of dataset size
and made use of noisy web-scale dataset in addition to ImageNet to achieve
state-of-the-art performance on various important vision tasks including image
classification, object detection and segmentation. Radosavovic et al. [12] made
use of self-supervision and a large unlabeled dataset to improve performance
on object and human keypoint detection tasks. These methods are able to uti-
lize large unannotated datasets, in addition to annotated datasets, and improve
performance over fully-supervised techniques.
3 Method
Our method consists of 3 stages shown in Fig. 1. First, we train a mitosis detector
on exhaustively labeled high-power-fields (HPFs) (Section 3.1); second, we mine
unannotated whole-slide-images (WSIs) for additional mitosis patches (Section
3.2); and finally, we re-train the mitosis detector using patches from both HPFs
and WSIs (Section 3.1).
3.1 Mitosis detector
We use a 12-layer ResNet [6], shown in Fig. 1b, for mitosis detection.
Training: This network is trained using patches of 128x128, which have the
label of either background or foreground (mitosis). These patches are sampled
from the following four sets depending on the training stage: BG-Rand, BG-Hard,
FG-Lab and FG-WSI (see Fig. 1a).
Set BG-Rand contains patches, which are sampled randomly with uniform
probability from HPFs such that their distance is greater than a fixed threshold
from previously selected background patches and all mitotic cells in that HPF.
BG-Hard consists of hard-negative mined patches, i.e. the false positive
patches extracted by applying the model (@ 30k iteration) to training HPFs.
The detections for each HPF are post-processed using non-maximum suppres-
sion (NMS), with a distance of 50 pixels, to remove duplicate.
Set FG-Lab contains patches centered at the annotated mitosis positions and
set FG-WSI includes mitosis patches extracted from the unlabeled whole-slide-
images (WSIs), details of which are provided in Section 3.2.
The network weights are optimized using ADAM optimizer [9], which min-
imizes the cross-entropy loss. We use a learning rate of 0.0001 for the first 20k
iterations, which is lowered to 0.00001 for the next 30k iterations and for the
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Fig. 1: Overview of the method. First, a mitosis detector is trained using labeled HPFs.
Then, additional mitosis are mined from unannotated WSIs and finally, the mitosis
detector is re-trained using patches from both labeled HPFs and unlabeled WSIs.
final 10k iterations, it is dropped to 0.000001. We use a batch size of 64 with a
fixed ratio of mitotic:background patches (2:62).
For the initial model, which makes use of only the labeled data, we train it
using patches from sets BG-Rand and FG-Lab for the first 30k iterations. Then,
hard-negative mining is used to obtain BG-Hard patches from the training HPF.
The next 30k iterations sample background patches from BG-Hard.
For the final model, which utilizes both the labeled and unlabeled data, the
foreground (mitosis) patches are sampled from FG-Lab and FG-WSI sets with
a fixed ratio and the background patches are sampled from BG-Rand for first
30k iterations, then hard-negative mining is used to obtain background patches
BG-Hard and the model is trained for another 30k iterations.
Data augmentation: Contrast variation is one of the biggest challenges in
automated analysis of histopathology images. Slides prepared using different
staining protocols and/or imaged using different scanners can have very different
color distributions (see Fig. 2). We use contrast transfer [13] to make our network
robust to these variations. During training, with a fixed probability, we change
the mean and standard deviation (in LAB color-space) of the HPF from which
a patch is sampled to the values from another randomly selected HPF. We also
use flipping, rotation and jitter to augment training samples.
Testing: At test time, we apply our method in a fully-convolutional manner.
Since the test images can be too large to fit in the current GPU memory, we pro-
cess them in windows of size 512x512. We pad (64 pixels) images by mirroring
and use overlapping (120 pixels) windows to handle zero-padding in convolu-
tional layers.
Once we have the probability maps of all windows predicted by our network,
we stitch and re-size them to the original image size. This is followed by NMS
with radius of 30 pixels to discard duplicate detections. Finally, we remove all
detections with score below 0.5.
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(a) Center 1 (b) Center 2 (c) Center 3 (d) Aperio (e) Hamamatsu
Fig. 2: Top row: Mitotic samples. Bottom row: Hard-negative samples. a-c) are from
TUPAC dataset and were collected from 3 different pathology centers. d-e) are from
MITOS14 dataset and they were scanned using two different scanners.
3.2 Mining mitosis from unlabeled WSIs
Current mitosis detectors typically have a high false negative rate at low values
of false positive rate (see Fig. 3c), so we use unlabeled data only for mining
mitosis samples. In order to ensure that the training does not derail, it is im-
portant that the additional mitosis samples have very few false positives (FPs).
We achieve this by using test-time data augmentations (flipping and rotations),
which removes many FPs with high score for only few of these transformations.
We apply our mitosis detector to whole-slide-images (WSIs) in a sliding win-
dow manner. Processing WSIs can be computationally expensive and applying
our mitosis detector on a single WSI can takes hours. In order to reduce the com-
putational demands, we skip windows which have mean RGB value greater than
a fixed threshold. Similarly, if the maximum score in a window is below a thresh-
old for the first transformation, then additional transformations are skipped.
4 Experiments
Dataset: We evaluate our method on two public mitosis datasets: TUPAC [2]
and MITOS14 [1]. We split these datasets into 80% train/20% val sets at case
level. Fig. 2 shows some mitosis and hard-negative patches from these datasets.
TUPAC (T) training set contains 1,552 mitotic cells annotated in 656 HPFs,
which are selected from 73 cases acquired from 3 different pathology labs. This
dataset also includes 500 WSIs from 500 cases in the training set which are
not annotated for mitosis. We use these WSIs as unlabeled data (U) for our
experiments. MITOS14 (M) training set consists of 1,502 mitotic cells marked
in 1,200 HPFs from 11 cases, each scanned using two different scanners: Aperio
Scanscope XT and Hamamatsu Nanozoomer 2.0-HT.
Metrics: We use the same criteria as TUPAC challenge [2] for evaluating mi-
tosis detection performance. A detection is considered as true positive (TP) if it
is within a radius of 30 pixels from any unmatched ground truth (GT). All other
detections are considered false positives (FP) and the GT annotations without
any detection in 30 pixel radius are counted as false negative (FN). Then, recall
(R), precision (P) and F1-Score (F1) are computed. When comparing different
models, we use maximum F1-Score at any threshold value; this mitigates the
problem of high sensitivity of F1-score to the selected threshold.
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Fig. 3: a) Performance improves almost linearly with the TUPAC training data size. b)
TUPAC validation error during training for various models. c) Precision-Recall curve
(TUPAC-val). F1-Scores @ threshold=0.5 are listed in the legend.
Table 1: Performance on both TUPAC/MITOS14-val sets for various combinations of
training sets: TUPAC (T), MITOS14 (M) and unlabeled WSIs (U).
Train set T M Train set T M
max(F1) max(F1) max(F1) max(F1)
T 0.655 0.552 T+U 0.673 0.579
M 0.378 0.678 M+U 0.466 0.674
T+M 0.653 0.660 T+M+U 0.684 0.655
Dataset size: We select 13 cases as validation set and then train three models
with the same hyper-parameters but with 30, 45 and 60 cases in the training set.
The results are plotted in Fig. 3a, which shows that the performance improves
almost linearly as we increase the training set size.
Cross-dataset generalization: Table 1 presents performance on TUPAC (T)
and MITOS14 (M) validation sets for models trained using various combina-
tions of training sets. The performance on TUPAC-val drops sharply when only
MITOS14 and unlabeled data (M and M+U in Table 1) is used for training,
which can be explained by the fact that TUPAC data is collected from multiple
pathology centers and as a result it has much larger variation than MITOS14.
The performance on MITOS14 is much more consistent irrespective of which
training set is used for training, indicating that at least some cases in TUPAC
data are representative of this dataset.
Impact of unlabeled WSIs: The experiments with unlabeled data (Table 1)
show that the performance on TUPAC-val set improves considerably for any
combination of TUPAC and MITOS14 dataset, indicating that mitosis samples
mined from unlabeled WSIs provide additional non-trivial information which is
helpful for learning a better model. For MITOS14-val on the other hand, the
use of unlabeled data only helps when MITOS14-train data is not used during
training. This is due to the unlabeled data having much larger contrast variation,
which makes the model generalize better (as performance on TUPAC always
improves) but does not provide much additional help when training set already
includes data from MITOS14.
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Table 2: Performance on TUPAC/MITOS14. The results in first two rows are on vali-
dation set, while the rest are on test sets.
TUPAC MITOS14
F1 Recall Precision F1 Recall Precision
Ours (T+M+U) 0.690 0.661 0.722 Ours (T+M+U) 0.642 0.605 0.683
Ours (T) 0.653 0.621 0.688 Ours (M) 0.620 0.496 0.828
Lunit [11] 0.652 - - CasNN [4] 0.482 0.507 0.460
IBM [19] 0.648 - - DeepMitosis [10] 0.437 0.443 0.431
Ours (T+M+U) 0.640 0.671 0.613 - - - -
Fig. 3b shows the performance on TUPAC-val during training for few models
trained using different combinations of T, M and U sets and Fig. 3c shows the
precision-recall curve for these models. Hard-negative mining is performed at
30k iterations and it consistently improves the F1-score by 5-10%.
Case-level performance: Mean and standard deviation of F1-Score at case
level for models trained using only T (0.622±0.236), T + M (0.619±0.227)
and T + M + U (0.636±0.191) also indicate that using only MITOS14 data
in addition to TUPAC has little overall benefit as this data is from a different
source. However, when unlabeled data from TUPAC is used, it leads to much
greater improvement in performance and the variation across cases reduces as
well, indicating that this automatically-labeled data is better for training than
the manually labeled data which comes from a different source.
Comparison with state-of-the-art: Table 2 compares the performance of our
method with top ranked methods on both TUPAC and MITOS14 datasets. On
MITOS14, our method has much higher F1-score on validation set (0.642) com-
pared to top ranked method on test set (0.482). On TUPAC test set, our method
ranks 3rd1 with F1-score of 0.64. We would like to point out that our submission
consists of a single model (@threshold=0.5) with minimal post-processing (i.e.
only NMS). Techniques such as test-time augmentation and ensembling can po-
tentially improve performance considerably. With ensembling alone leading to
∼10% improvement in F1-score of some methods [4,16]) on this task.
5 Discussion
In this paper, we have presented a semi-supervised mitosis detection method,
which benefits from a large amount of unlabeled data, that is readily available
in histopathology. This method has the potential to benefit other detection and
segmentation tasks in many medical and biological research areas, where labeled
data is scarce and unlabeled data is abundant. It is clear from current methods
[8,12] and our own results that once a method reaches a sufficient performance
level, it can be used to generate pseudo-labels for unlabeled data, which can then
be used to re-train it, improving performance. However, it is worth investigating,
where that sufficient performance level lies for various tasks.
An important future direction is to explore the upper limit of performance
that is attainable with current annotation procedures. This upper-limit exists,
1 Out of 20 methods listed at http://tupac.tue-image.nl/node/62
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due to the unavoidable noise in pathologist mitosis annotation. State-of-the-art
methods already obtain similar performance to that of pathologists, but these
methods have poor generalization when applied to data from different sources
[16]. Using larger and more diverse datasets can resolve this issue and semi-
supervised techniques can be highly beneficial in these scenarios. In addition,
more objective annotation techniques (e.g. using PHH3 labeling [18]) have the
potential of improving performance considerably, which may result in future
automated methods outperforming experienced pathologists.
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